The potential of prime editing has been tried on two muscular diseases: Duchenne muscular dystrophy, caused by a mutation in the DMD gene, and spinal muscular atrophy, caused by a mutation in the SMN2 gene (Table 5). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.